2020
DOI: 10.1016/s2213-2600(20)30121-1
|View full text |Cite
|
Sign up to set email alerts
|

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
470
1
39

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 480 publications
(515 citation statements)
references
References 50 publications
(48 reference statements)
1
470
1
39
Order By: Relevance
“…As respiratory failure worsens, there is a need for extracorporeal membrane oxygenation due to hypoxemia and distributive and cardiogenic shock. 49 The large majority of mortality in these patients is attributed to respiratory failure and shock. 6 These observations-the frequent development of ARDS and the possibility of cardiac dysfunction in addition to active expanding lung infiltrates-make it crucial for physicians to be vigilant with fluid management strategies.…”
Section: Covid-19 In the Spotlightmentioning
confidence: 99%
“…As respiratory failure worsens, there is a need for extracorporeal membrane oxygenation due to hypoxemia and distributive and cardiogenic shock. 49 The large majority of mortality in these patients is attributed to respiratory failure and shock. 6 These observations-the frequent development of ARDS and the possibility of cardiac dysfunction in addition to active expanding lung infiltrates-make it crucial for physicians to be vigilant with fluid management strategies.…”
Section: Covid-19 In the Spotlightmentioning
confidence: 99%
“…The effectiveness of ECMO as a therapy for COVID-19 has not yet been established, but there are reports of it saving lives in severe cases (5)(6)(7), and emergency guidelines have been promulgated (8,9). Treatment of respiratory failure via ECMO requires specialized knowledge and training for not only doctors but also nurses, clinical engineers, and several other staff members (10,11). ECMO is known to improve the prognosis for patients in facilities that have used it in more cases (4); this therapy requires considerable experience and skill on the part of the medical team administering it.…”
Section: Ecmomentioning
confidence: 99%
“…[3][4][5] Despite the recommended initial recommended approaches for adult respiratory distress syndrome associated with COVID-19, overall oxygenation may deteriorate clinically as tracked by a falling blood oxygen tension/inspired oxygen ratio. [14][15] When this important ratio drops below 150 mmHg, it should trigger consideration of the following acute care interventions to improve gas exchange: lung recruitment maneuvers, positive end-expiratory pressure titration, neuromuscular blockade, and prone positioning. [3][4][5] Inhaled selective pulmonary vasodilators such as nitric oxide and epoprostenol may be considered in specialized centers to further optimize matching of ventilation and perfusion matching throughout ventilated lung areas.…”
Section: Consider the Challenges In Critical Care For Acute Respiratomentioning
confidence: 99%
“…[3][4][5] The contraindications for ECMO in patients with COVID-19 should be hospital-specific, with consideration of local factors such as team experience and resource availability. [14][15] Clinical risk factors such as advanced age, frailty, prior lung disease, diabetes, heart failure, and immunosuppression may also qualify as contraindications to 4 ECMO. [14][15][16] The indications and contraindications to ECMO during the coronavirus crisis should be adjusted in real-time to local factors.…”
Section: Consider the Challenges In Critical Care For Acute Respiratomentioning
confidence: 99%
See 1 more Smart Citation